Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 19 studies | 44% ± 16% | |
endothelial cell | 7 studies | 22% ± 6% | |
oligodendrocyte | 5 studies | 26% ± 8% | |
GABAergic neuron | 4 studies | 41% ± 14% | |
astrocyte | 4 studies | 31% ± 14% | |
glutamatergic neuron | 4 studies | 47% ± 14% | |
oligodendrocyte precursor cell | 4 studies | 23% ± 6% | |
microglial cell | 3 studies | 18% ± 2% | |
epithelial cell | 3 studies | 30% ± 4% | |
neuron | 3 studies | 24% ± 8% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 40% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 532.45 | 2636 / 2642 | 97% | 3.60 | 687 / 705 |
thymus | 100% | 677.43 | 653 / 653 | 97% | 3.42 | 585 / 605 |
prostate | 100% | 458.40 | 245 / 245 | 94% | 2.53 | 470 / 502 |
breast | 100% | 503.08 | 459 / 459 | 93% | 3.20 | 1039 / 1118 |
kidney | 100% | 426.66 | 89 / 89 | 85% | 2.12 | 763 / 901 |
intestine | 100% | 530.39 | 966 / 966 | 84% | 2.02 | 445 / 527 |
stomach | 100% | 463.24 | 359 / 359 | 84% | 2.02 | 240 / 286 |
pancreas | 99% | 252.34 | 325 / 328 | 83% | 1.64 | 147 / 178 |
bladder | 100% | 427.57 | 21 / 21 | 77% | 1.87 | 388 / 504 |
esophagus | 100% | 403.80 | 1444 / 1445 | 74% | 1.49 | 135 / 183 |
lung | 100% | 541.00 | 576 / 578 | 74% | 1.72 | 851 / 1155 |
uterus | 100% | 465.14 | 170 / 170 | 73% | 1.76 | 333 / 459 |
ovary | 100% | 419.64 | 180 / 180 | 68% | 1.46 | 292 / 430 |
adrenal gland | 98% | 295.38 | 253 / 258 | 69% | 1.79 | 158 / 230 |
skin | 100% | 331.49 | 1801 / 1809 | 60% | 1.29 | 283 / 472 |
liver | 93% | 168.41 | 211 / 226 | 24% | 0.40 | 96 / 406 |
blood vessel | 100% | 560.34 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 541.02 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 1.07 | 1 / 1 |
adipose | 100% | 409.11 | 1203 / 1204 | 0% | 0 | 0 / 0 |
muscle | 99% | 320.92 | 794 / 803 | 0% | 0 | 0 / 0 |
heart | 97% | 397.38 | 837 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 71% | 149.41 | 659 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 58% | 1.27 | 26 / 45 |
lymph node | 0% | 0 | 0 / 0 | 41% | 0.63 | 12 / 29 |
eye | 0% | 0 | 0 / 0 | 41% | 0.79 | 33 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0046940 | Biological process | nucleoside monophosphate phosphorylation |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0031965 | Cellular component | nuclear membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0004017 | Molecular function | adenylate kinase activity |
GO_0004550 | Molecular function | nucleoside diphosphate kinase activity |
GO_0050145 | Molecular function | nucleoside monophosphate kinase activity |
GO_0016887 | Molecular function | ATP hydrolysis activity |
GO_0005524 | Molecular function | ATP binding |
Gene name | AK9 |
Protein name | Adenylate kinase 8 (EC 2.7.4.3) (EC 2.7.4.6) (ATP-AMP transphosphorylase 8) Adenylate kinase 9 Adenylate kinase 9 (AK 9) (EC 2.7.4.4) (EC 2.7.4.6) (Adenylate kinase domain-containing protein 1) (Adenylate kinase domain-containing protein 2) Cilia- and flagella-associated protein 206 nucleoside-diphosphate kinase (EC 2.7.4.6) |
Synonyms | C6orf224 AKD2 AKD1 C6orf199 |
Description | FUNCTION: Involved in maintaining the homeostasis of cellular nucleotides by catalyzing the interconversion of nucleoside phosphates. Has both nucleoside monophosphate and diphosphate kinase activities. Catalyzes the phosphorylation of AMP, dAMP, CMP and dCMP with ATP as phosphate donor and of CMP with GTP as phosphate donor. Also catalyzes the production of ATP, CTP, GTP, UTP, dATP, dCTP, dGTP and TTP from the corresponding diphosphate substrates with either ATP or GTP as phosphate donor. Shows substrate preference of CDP > UDP > ADP > GDP > TDP. . FUNCTION: Nucleoside monophosphate (NMP) kinase that catalyzes the reversible transfer of the terminal phosphate group between nucleoside triphosphates and monophosphates. Has highest activity toward AMP, and weaker activity toward dAMP, CMP and dCMP. Also displays broad nucleoside diphosphate kinase activity. . |
Accessions | A0A075B7F5 H0YCD1 J3KP89 ENST00000355283.1 [Q5TCS8-5] ENST00000524674.5 H7C505 ENST00000491875.5 E9PPU7 ENST00000490722.1 ENST00000470564.5 ENST00000605986.5 ENST00000424296.7 [Q5TCS8-4] H7C517 ENST00000285397.9 [Q5TCS8-2] ENST00000368948.6 ENST00000448084.6 H0Y8C5 ENST00000532976.1 E9PPM3 Q5TCS8 |